Data is not available at this time.
Precision Optics Corporation, Inc. operates in the specialized optics and photonics industry, providing high-precision optical components and systems for medical, defense, and industrial applications. The company’s core revenue model is driven by custom-designed optical solutions, including endoscopes, imaging systems, and micro-optics, tailored to meet stringent technical requirements. Its expertise in miniaturization and advanced manufacturing positions it as a critical supplier for minimally invasive medical devices and high-performance defense systems. Precision Optics serves niche markets where precision and reliability are paramount, competing with larger players through agility and technical specialization. The company’s focus on R&D and partnerships with OEMs underscores its role as an innovator in optical technology, though its smaller scale limits broad market penetration. Its market positioning hinges on delivering high-value, low-volume products that command premium pricing due to their specialized nature.
Precision Optics reported revenue of $19.1 million for FY 2024, reflecting its niche market focus. However, the company posted a net loss of $2.95 million, with diluted EPS of -$0.49, indicating ongoing profitability challenges. Operating cash flow was negative at $2.68 million, exacerbated by capital expenditures of $0.27 million, highlighting inefficiencies in converting revenue to cash. The lack of dividend payments aligns with its reinvestment priorities.
The company’s negative earnings and cash flow underscore weak earnings power, likely due to high R&D and operational costs relative to its revenue base. Capital efficiency appears strained, with limited free cash flow generation. The diluted EPS of -$0.49 further emphasizes the need for improved scalability or cost management to achieve sustainable profitability.
Precision Optics holds $0.41 million in cash and equivalents against $3.43 million in total debt, signaling liquidity constraints. The debt-heavy balance sheet raises concerns about financial flexibility, particularly given negative operating cash flow. Shareholder equity is likely under pressure, though specific figures are unavailable. The company’s financial health appears fragile, necessitating careful monitoring of debt obligations.
Revenue growth trends are unclear without prior-year comparisons, but the net loss suggests stagnant or declining margins. The absence of dividends reflects a reinvestment strategy, though the lack of profitability limits growth funding options. The company’s future growth may hinge on expanding its customer base or securing higher-margin contracts in its specialized markets.
With a negative EPS and weak cash flow, traditional valuation metrics are challenging to apply. Market expectations likely center on turnaround potential, given its niche expertise. The stock’s valuation may reflect speculative interest in its optical technology rather than near-term earnings prospects.
Precision Optics’ strategic advantage lies in its technical expertise and niche market focus, but financial instability poses significant risks. The outlook depends on improving operational efficiency and securing stable, high-margin contracts. Success in medical or defense applications could drive long-term value, though near-term challenges remain acute.
Company filings (CIK: 0000867840), FY 2024 preliminary data
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |